Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
- Previous Close
73.48 - Open
72.80 - Bid 75.00 x --
- Ask 75.02 x --
- Day's Range
72.80 - 75.34 - 52 Week Range
46.30 - 88.38 - Volume
3,417,191 - Avg. Volume
3,113,128 - Market Cap (intraday)
30.51B - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
33.94 - EPS (TTM)
2.21 - Earnings Date --
- Forward Dividend & Yield 0.41 (0.52%)
- Ex-Dividend Date May 23, 2024
- 1y Target Est
--
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China. The company provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is based in Xiamen, China.
www.amoytop.comRecent News: 688278.SS
View MorePerformance Overview: 688278.SS
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688278.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688278.SS
View MoreValuation Measures
Market Cap
29.89B
Enterprise Value
29.09B
Trailing P/E
34.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.19
Price/Book (mrq)
10.87
Enterprise Value/Revenue
9.88
Enterprise Value/EBITDA
29.58
Financial Highlights
Profitability and Income Statement
Profit Margin
29.38%
Return on Assets (ttm)
22.36%
Return on Equity (ttm)
39.97%
Revenue (ttm)
2.82B
Net Income Avi to Common (ttm)
827.6M
Diluted EPS (ttm)
2.21
Balance Sheet and Cash Flow
Total Cash (mrq)
584.55M
Total Debt/Equity (mrq)
0.44%
Levered Free Cash Flow (ttm)
-33.11M